Alaska Permanent Fund’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
EC
Alaska Permanent Fund's JAZZ Position: Q2 2025 in Review
Alaska Permanent Fund sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2025, closing a stake of 23,149 shares — an estimated $2.71M sold.
Alaska Permanent Fund first reported a position in JAZZ in Q1 2020 and held it in 20 quarters. The position peaked at $2.85M in Q4 2024. 502 funds tracked by Wall St. Rank hold JAZZ as of Q2 2025.
- Alaska Permanent Fund reported no remaining Jazz Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
- Alaska Permanent Fund sold 23,149 Jazz Pharmaceuticals shares in Q2 2025, an estimated $2.71M.
- Alaska Permanent Fund first reported a position in Jazz Pharmaceuticals in Q1 2020 and held it in 20 quarters.
- Alaska Permanent Fund's Jazz Pharmaceuticals position peaked at $2.85M in Q4 2024.
- 502 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2025.
Based on Alaska Permanent Fund's 13F filing for Q2 2025, filed 14 Aug 2025.